Home › Leiomyosarcoma
Pag-aaral pangklinika para sa Leiomyosarcoma na nagre-recruit sa U.S.
19 pag-aaral para sa Leiomyosarcoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX7 pag-aaral
- Boston, MA5 pag-aaral
- New York City, NY4 pag-aaral
- Santa Monica, CA4 pag-aaral
- Chicago, IL4 pag-aaral
- Nashville, TN3 pag-aaral
- Ann Arbor, MI3 pag-aaral
- Rochester, MN3 pag-aaral
- Columbus, OH3 pag-aaral
- Miami, FL3 pag-aaral
- Queens, NY3 pag-aaral
- St. Louis, MO3 pag-aaral
- Aurora, CO3 pag-aaral
Ayos sa estado
- California9 pag-aaral
- Colorado3 pag-aaral
- Florida4 pag-aaral
- Illinois4 pag-aaral
- Massachusetts5 pag-aaral
- Michigan4 pag-aaral
- Minnesota3 pag-aaral
- Missouri3 pag-aaral
- New York4 pag-aaral
- Ohio5 pag-aaral
- Tennessee4 pag-aaral
- Texas7 pag-aaral
- Virginia3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05711615Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT01793168STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT06975293A Study of Ivonescimab in People With Leiomyosarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07516925Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06498648AOH1996 for the Treatment of Refractory Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT05227326XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06571734Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT04031677Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06528769NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06239272A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07633756Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07628634Localized Leiomyosarcoma Biomarker Protocol
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT04925089Metastatic Leiomyosarcoma Biomarker Protocol
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT05653388A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT06789172Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT03016819Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
Nagre-recruitPhase 2
Edad 65 hanggang 100 · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT07125183Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 13, 2025 · NCT06875700Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 24, 2025 · NCT04535271Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.